Lynx1 Capital Management’s Pliant Therapeutics PLRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.94M Hold
1,798,070
– – 0.3% 13
2026
Q2
$2.05M Buy
+1,798,070
New +$2.19M 0.24% 12

Other funds holding PLRX

Lynx1 Capital Management's PLRX Position: Q3 2026 in Review

Lynx1 Capital Management held its Pliant Therapeutics (PLRX) position steady in Q3 2026 at 1,798,070 shares worth $1.94M. The position accounts for 0.3% of the portfolio, ranked #13.

Lynx1 Capital Management first reported a position in PLRX in Q2 2026 and has held it in 2 quarters since. The position peaked at $2.05M in Q2 2026. 84 funds tracked by Wall St. Rank hold PLRX as of Q3 2026.

  • Lynx1 Capital Management held 1,798,070 shares of Pliant Therapeutics worth $1.94M as of Q3 2026.
  • Lynx1 Capital Management left its Pliant Therapeutics share count unchanged in Q3 2026.
  • Pliant Therapeutics made up 0.3% of Lynx1 Capital Management's portfolio in Q3 2026, its #13 holding.
  • Lynx1 Capital Management first reported a position in Pliant Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • Lynx1 Capital Management's Pliant Therapeutics position peaked at $2.05M in Q2 2026.
  • 84 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q3 2026.

Based on Lynx1 Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.